Your browser doesn't support javascript.
loading
Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass / 南方医科大学学报
Article in Zh | WPRIM | ID: wpr-781257
Responsible library: WPRO
ABSTRACT
OBJECTIVE@#To compare the performance of serum cancer antigen 125 (CA125), human epididymis protein 4 (HE4), Risk of Ovarian Malignancy Algorithm (ROMA) and Copenhagen index (CPH-I) for differential diagnosis of benign and malignant diseases in patients with ovarian mass.@*METHODS@#We retrospectively analyzed the data of 719 women with pelvic mass, and the performance of preoperative serum levels of CA125 and HE4, ROMA and CPH-I for differential diagnosis of the masses was compared.@*RESULTS@#Of the 710 women analyzed, 531 were diagnosed with benign ovarian lesions, 44 with borderline ovarian tumors (BOTs), 119 with epithelial ovarian cancers (EOCs), and 25 with non-EOCs. In differentiating ovarian cancer (OC) and BOT from benign lesions, the area under the receiver-operator characteristic (ROC) curve (AUC) was 0.854 for HE4, 0.856 for ROMA, 0.854 for CPH-I, and 0.792 for CA125, demonstrating better diagnostic performance of HE4, ROMA, and CPH-I than CA125 alone; the diagnostic sensitivity was 56.9% for HE4, 70.2% for CA125, 69.1% for ROMA, and 63.8% for CPH-I; the specificity was the best with HE4 (94.4%) and CPH-I (94.7%). In sub-analysis of EOC benign lesions, the AUCs of HE4, ROMA, and CPH-I increased to 0.946, 0.947, and 0.943, respectively, all greater than that of CA125 (0.888). In other sub-analyses, HE4, ROMA, and CPH-I all showed greater AUCs than CA125 alone.@*CONCLUSIONS@#This study confirms the accuracy of HE4, ROMA, and CPH-I for differentiating malignant from benign ovarian mass, and all these 3 tests show better performance than CA125. Furthermore, HE4 and CPH-I is superior to ROMA and CA125 in terms of specificity, while CA125 and ROMA have better diagnostic sensitivities.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Ovarian Neoplasms / Algorithms / Proteins / Biomarkers, Tumor / Retrospective Studies / Neoplasms, Glandular and Epithelial / CA-125 Antigen / Carcinoma, Ovarian Epithelial / WAP Four-Disulfide Core Domain Protein 2 Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Female / Humans Language: Zh Journal: Journal of Southern Medical University Year: 2019 Type: Article
Full text: 1 Index: WPRIM Main subject: Ovarian Neoplasms / Algorithms / Proteins / Biomarkers, Tumor / Retrospective Studies / Neoplasms, Glandular and Epithelial / CA-125 Antigen / Carcinoma, Ovarian Epithelial / WAP Four-Disulfide Core Domain Protein 2 Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Female / Humans Language: Zh Journal: Journal of Southern Medical University Year: 2019 Type: Article